SUPERNUS PHARMACEUTICALS, INC. (SUPN) Reports Material Event to SEC
Filing Details SUPERNUS PHARMACEUTICALS, INC. (NASDAQ:SUPN) filed a Form 8-K with the Securities and Exchange Commission on August 03, 2026, disclosing a material event. Market…
Read more
